Legislation

To read the full text, visit the Federal Register of Legislation

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

To read the full text, visit the Federal Register of Legislation.

The Poisons Standard classifies medicines and poisons into different Schedules, signifying the degree of risk and the control recommended to be exercised over their availability to the public. Sometimes referred to as the Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP).

The Therapeutic Goods Act 1989 provides for the establishment and maintenance of a national system of controls relating to the quality, safety, efficacy and timely availability of therapeutic goods that are used in Australia or exported from Australia.

This Specification facilitates the release of de-identified adverse event report information recorded in the Adverse Event Management System (AEMS) portal to sponsors.

This Specification facilitates the release of specified kinds of therapeutic goods information relating to adverse events following immunisation to specified persons or bodies.

This Specification facilitates the publication of certain therapeutic goods information relating to complaints and investigations by the TGA in respect of the advertising of therapeutic goods and dissemination of generic information.

This Specification facilitates the public release of therapeutic goods information relating to advisory committee meetings.

This Specification facilitates the release of therapeutic goods information relating to advisory committee meetings to relevant persons or bodies for specified purposes.

The Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and efficacy standards.

The Act amends the Therapeutic Goods Act 1989 to improve regulation of therapeutic goods in Australia, enhancing safety and efficacy standards.